Gefitinib in non-small cell lung cancer
Nakagawa, K.
Nihon Rinsho. Japanese Journal of Clinical Medicine 62(7): 1312-1320
2004
ISSN/ISBN: 0047-1852 PMID: 15283149 Document Number: 580675
Document emailed within 1 workday
Related Documents
Tanović, A.; Alfaro, V. 2004: Gefitinib: current status in the treatment of non-small cell lung cancer Drugs of Today 40(10): 809-827Wang, B.; Zhang, X-ru.; Chu, D-tong. 2007: Gefitinib in the treatment of male patients with advanced non-small-cell lung cancer Zhonghua Zhong Liu Za Zhi 29(7): 549-551
Hashizume, T.; Ogura, T.; Kozawa, S.; Kobayashi, N.; Tagawa, A.; Miyazawa, N.; Watanuki, Y.; Takahashi, H. 2006: Gefitinib as a first-line therapy in patients with advanced non-small cell lung cancer Gan to Kagaku Ryoho. Cancer and ChemoTherapy 33(4): 467-470
Gu, A.-q.; Wang, H.-m.; Shi, C.-l.; Xiong, L.-w.; Gao, Z.-q.; Han, B.-h. 2010: Clinical observation of gefitinib for the treatment of 125 cases with advanced non-small cell lung cancer Zhonghua Zhong Liu Za Zhi 32(1): 71-74
Warthan, M.M.; Jumper, C.A.; Smith, J.L. 2004: Acneiform eruption induced by Iressa (gefitinib) tablets used to treat non-small cell lung cancer Journal of drugs in dermatology: JDD 3(5): 569-570
Zhang, L.; Wang, S.-L.; Zhang, X.-T.; Li, L.-Y.; Wang, M.-Z. 2007: Efficacy and safety of gefitinib monotherapy for Chinese elderly patients with advanced non-small cell lung cancer Zhonghua Nei Ke Za Zhi 46(5): 392-395
Mencoboni, M.; Bergaglio, M.; Serra, M.; Ivaldi, G.P.; Tredici, S.; Racchi, O.; Rebella, L.; Galbusera, V.; Grosso, M.; Faravelli, B. 2007: Maintenance therapy with gefitinib after first-line chemotherapy in patients affected by advanced non-small cell lung cancer Anticancer Research 27(6c): 4425-4429
Nishikawa, M.; Kusano, N.; Yoshimoto, N.; Ito, M.; Kakemizu, N.; Nozaki, M.; Fujiwara, M.; Momiyama, M.; Kido, Y. 2006: Prolonged survival of gefitinib treatment in patients with advanced and previously treated non-small cell lung cancer Gan to Kagaku Ryoho. Cancer and ChemoTherapy 33(10): 1437-1440
Fujimoto, H.; Oyama, T.; Suito, T.; Hashimoto, K.; Kameyama, Y.; Yasuda, H.; Ishizuka, H. 2010: A case of complete response treated by S-1 with concurrent radiotherapy for a gefitinib-resistant non-small cell lung cancer patient Gan to Kagaku Ryoho. Cancer and ChemoTherapy 37(2): 295-298
Suzumura, T.; Kimura, T.; Kudoh, S.; Umekawa, K.; Nagata, M.; Tanaka, H.; Mitsuoka, S.; Yoshimura, N.; Kira, Y.; Hirata, K. 2012: Comparison of adverse events of erlotinib with those of gefitinib in patients with non-small cell lung cancer: a case-control study in a Japanese population Osaka City Medical Journal 58(1): 25-34
Acharyya, S.; Sau, S.; Dasgupta, P.; Chakraborty, A.; Gangopadhyay, S. 2012: Skin rash as a surrogate marker of clinical response of targeted therapy using gefitinib in advanced or metastatic non-small-cell lung cancer--a retrospective study Journal of the Indian Medical Association 110(7): 474-6 493
Protsenko, S.A.; Rudakova, A.V.; Moiseenko, F.V.; Levchenko, E.V.; Matsko, D.E.; Ivantsov, A.O.; Semënov, I.I.; Ievleva, A.G.; Mitiushkina, N.V.; Togo, A.V.; Novik, A.V.; Imianitov, E.N.; Moiseenko, V.M. 2012: Pharmacoeconomic analysis of gefitinib therapy in patients with non-cell cell lung cancer Voprosy Onkologii 58(3): 352-358
Neill, H.B.; Miller, A.A.; Clamon, G.H.; Perry, M.C.; Crawford, J.; Green, M.R. 1997: A phase Ii study evaluating the efficacy of carboplatin, etoposide, and paclitaxel with granulocyte colony-stimulating factor in patients with stage IIIB and IV non-small cell lung cancer and extensive small cell lung cancer Seminars in Oncology 24(4 Suppl 12: S12
Munzuroglu, F.; Erturan, S.; Oz, B.; Dincbas, F.O.; Demir, G. 2009: Non small cell lung cancer within the small cell lung cancer radiotherapy field after 11 years Journal of Buon: Official Journal of the Balkan Union of Oncology 14(2): 313-316
Bando, T.; Fujimura, M.; Kasahara, K.; Matsuda, T. 1998: Significance of Na+, K(+)-ATPase on intracellular accumulation of cis-diamminedichloroplatinum(II) in human non-small-cell but not in small-cell lung cancer cell lines Anticancer Research 18(2a): 1085-1089
Doyle, L.A.; Cuttitta, F.; Mulshine, J.L.; Bunn, P.A.; Minna, J.D. 1987: Markedly different antibody responses to immunized small cell and non-small cell lung cancer cells Cancer Research 47(19): 5009-5013
Kobyakov, D.S.; Avdalyan, A.M.; Lazarev, A.F.; Lushnikova, Y.L.; Nepomnyashikh, L.M. 2015: The Processes of cell Proliferation, Apoptosis and Angiogenesis in Pathologically Unchanged Lung and in Non-Small cell Lung Cancer Morfologiia 148(5): 65-70
Levin, W.J.; Press, M.F.; Gaynor, R.B.; Sukhatme, V.P.; Boone, T.C.; Reissmann, P.T.; Figlin, R.A.; Holmes, E.C.; Souza, L.M.; Slamon, D.J. 1995: Expression patterns of immediate early transcription factors in human non-small cell lung cancer. the Lung Cancer Study Group Oncogene 11(7): 1261-1269
Evans, W.K. 1997: Cost-effectiveness of gemcitabine in stage IV non-small cell lung cancer: an estimate using the Population Health Model lung cancer module Seminars in Oncology 24(2 Suppl 7: S7
Aoe, K.; Hiraki, A.; Murakami, T.; Maeda, T.; Umemori, Y.; Katayama, H.; Eda, R.; Takeyama, H. 2005: Sudden onset of interstitial lung disease induced by gefitinib in a lung cancer patient with multiple drug allergy Anticancer Research 25(1b): 415-418